Inata Yu, Takeuchi Muneyuki
Department of Intensive Care Medicine, Osaka Women's and Children's Hospital, 840 Murodo-cho, Izumi, Osaka 594-1101 Japan.
J Intensive Care. 2017 May 30;5:30. doi: 10.1186/s40560-017-0227-y. eCollection 2017.
The high-flow nasal cannula (HFNC) system has been widely used for children in various clinical settings. However, the physiological and clinical impact of HFNC therapy on the pediatric patient with respiratory distress after cardiac surgery has not been thoroughly investigated.
It seems logical to use HFNC as a primary therapy for post-extubation respiratory failure after congenital heart surgery, in which low cardiac output syndrome and upper airway obstruction are commonly encountered; the HFNC therapy alleviates the work of breathing and large negative swings of intrathoracic pressure, which in turn helps to decrease the systemic ventricular afterload. When applying HFNC to patients after congenital heart surgery, however, consideration must be given to its diverse effects on hemodynamics because of the complex respiratory and cardiac pathophysiology in these patients. The positive pressure generated by HFNC can exert different effects on pulmonary vascular resistance depending on the lung condition, while its impact on cardiac output may also differ depending on the cardiac physiology. The hemodynamic effects of HFNC may become even more complex in a patient with a single ventricle. To better assess its physiologic effects in patients after cardiac surgery, future studies could utilize various modalities including esophageal balloon catheters, electrical impedance tomography, and near-infrared spectroscopy. At the same time, studies should focus on specific types of cardiac pathophysiology or surgery when evaluating the effects of HFNC, since it may exert various effects, depending on the cardiac physiology or preoperative pulmonary hemodynamics. Lastly, the optimal flow rate at which the benefit of HFNC is maximized through favorable cardiopulmonary interactions should be determined in future studies.
Further studies are needed to better understand the effect of HFNC in different cardiac and respiratory physiologies, given their complexity in pediatric patients after cardiac surgery.
高流量鼻导管(HFNC)系统已在各种临床环境中广泛应用于儿童。然而,HFNC治疗对心脏手术后出现呼吸窘迫的儿科患者的生理和临床影响尚未得到充分研究。
对于先天性心脏手术后拔管后呼吸衰竭,使用HFNC作为主要治疗方法似乎是合理的,因为先天性心脏手术中常出现低心排血量综合征和上呼吸道梗阻;HFNC治疗可减轻呼吸功和胸内压的大幅负向波动,进而有助于降低体循环心室后负荷。然而,在对先天性心脏手术后的患者应用HFNC时,由于这些患者复杂的呼吸和心脏病理生理学,必须考虑其对血流动力学的多种影响。HFNC产生的正压根据肺部情况可对肺血管阻力产生不同影响,而其对心输出量的影响也可能因心脏生理状况而异。对于单心室患者,HFNC的血流动力学影响可能会更加复杂。为了更好地评估其在心脏手术后患者中的生理作用,未来的研究可以采用多种方式,包括食管气囊导管、电阻抗断层扫描和近红外光谱。同时,在评估HFNC的效果时,研究应关注特定类型的心脏病理生理学或手术,因为它可能根据心脏生理状况或术前肺血流动力学产生多种影响。最后,未来研究应确定通过良好的心肺相互作用使HFNC益处最大化的最佳流速。
鉴于心脏手术后儿科患者的心脏和呼吸生理状况复杂,需要进一步研究以更好地了解HFNC的作用。